# Cadrenal Therapeutics, Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:f227606f-090b-4b0c-a0c5-48947253569f | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/cadrenal-therapeutics-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 22 | | Claims under review | 1 | | Evidence records | 7 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-16T13:53:50.695151+00:00 | | Last reviewed | 2026-10-16T13:53:50.695151+00:00 | ## Identity - Legal name: Cadrenal Therapeutics, Inc. - Display name: Cadrenal Therapeutics, Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-17T02:38:38.277963+00:00 | | Completeness | 0.409 | | Record Quality | 0.834 | | Directors | 4 | | Committees | 6 | | Governance events | 14 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Glynn Wilson: Director. Status: current. Independent: true. Since: 2023-01-01. Committees: Audit (member); Audit; Nominating and Governance · Chair (member); Nominating and Governance (chair). claim_id=alpha:claim:company:f227606f-090b-4b0c-a0c5-48947253569f:leadership_role:5 - John R. Murphy: Director. Status: current. Independent: true. Since: 2023-01-01. Committees: Audit (chair); Audit · Chair; Compensation (member); Compensation (member). claim_id=alpha:claim:company:f227606f-090b-4b0c-a0c5-48947253569f:leadership_role:6 - Quang X. Pham: Director. Status: current. Independent: false. Since: 2022-01-01. claim_id=alpha:claim:company:f227606f-090b-4b0c-a0c5-48947253569f:leadership_role:7 - Steven Zelenkofske: Director. Status: current. Independent: true. Since: 2023-01-01. Committees: Audit (member); Audit; Compensation · Chair; Nominating and Governance (member); Compensation (chair); Nominating and Governance (member). claim_id=alpha:claim:company:f227606f-090b-4b0c-a0c5-48947253569f:leadership_role:8 ## Committees - Audit (audit). Chair: John R. Murphy. Members: John R. Murphy (chair, current); Glynn Wilson (member, current); Steven Zelenkofske (member, current). committee_id=alpha:committee:cadrenal-therapeutics-inc:audit - Audit · Chair; Compensation (audit). Chair: NOT_PUBLISHED. Members: John R. Murphy (member, current). committee_id=alpha:committee:cadrenal-therapeutics-inc:audit-chair-compensation - Audit; Compensation · Chair; Nominating and Governance (audit). Chair: NOT_PUBLISHED. Members: Steven Zelenkofske (member, current). committee_id=alpha:committee:cadrenal-therapeutics-inc:audit-compensation-chair-nominating-and-governance - Audit; Nominating and Governance · Chair (audit). Chair: NOT_PUBLISHED. Members: Glynn Wilson (member, current). committee_id=alpha:committee:cadrenal-therapeutics-inc:audit-nominating-and-governance-chair - Compensation (compensation). Chair: Steven Zelenkofske. Members: Steven Zelenkofske (chair, current); John R. Murphy (member, current). committee_id=alpha:committee:cadrenal-therapeutics-inc:compensation - Nominating and Governance (nominating_governance). Chair: Glynn Wilson. Members: Glynn Wilson (chair, current); Steven Zelenkofske (member, current). committee_id=alpha:committee:cadrenal-therapeutics-inc:nominating-and-governance ## Executive leadership - James J. Ferguson III: Chief Medical Officer. Status: current. claim_id=alpha:claim:company:f227606f-090b-4b0c-a0c5-48947253569f:leadership_role:9 - Jeffrey Cole: Chief Operating Officer [COO]. Status: current. claim_id=alpha:claim:company:f227606f-090b-4b0c-a0c5-48947253569f:leadership_role:10 - Matthew Szot: Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:f227606f-090b-4b0c-a0c5-48947253569f:leadership_role:11 - Quang X. Pham: Chairman and Chief Executive Officer [CEO]. Status: current. claim_id=alpha:claim:company:f227606f-090b-4b0c-a0c5-48947253569f:leadership_role:12 ## Governance events - EXECUTIVE_APPOINTED: James J. Ferguson III executive of Cadrenal Therapeutics, Inc., effective 2026-03-31. Effective: 2026-03-31. Detected: 2026-10-16T13:53:50.695151+00:00. event_id=alpha:event:transition:1nrxeow140l304 - EXECUTIVE_APPOINTED: Jeffrey Cole executive of Cadrenal Therapeutics, Inc., effective 2026-03-31. Effective: 2026-03-31. Detected: 2026-10-16T13:53:50.695151+00:00. event_id=alpha:event:transition:na7n8icmcph8 - CFO_CHANGED: Matthew Szot executive of Cadrenal Therapeutics, Inc., effective 2026-03-31. Effective: 2026-03-31. Detected: 2026-10-16T13:53:50.695151+00:00. event_id=alpha:event:transition:1t01nt4eclzl8 - CEO_CHANGED: Quang X. Pham executive of Cadrenal Therapeutics, Inc., effective 2026-03-31. Effective: 2026-03-31. Detected: 2026-10-16T13:53:50.695151+00:00. event_id=alpha:event:transition:v9lgzl17w74cr - DIRECTOR_APPOINTED: Glynn Wilson seat on Cadrenal Therapeutics, Inc., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-16T13:53:50.695151+00:00. event_id=alpha:event:transition:1od2ju31k14mw9 - DIRECTOR_APPOINTED: John R. Murphy seat on Cadrenal Therapeutics, Inc., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-16T13:53:50.695151+00:00. event_id=alpha:event:transition:hwjs4ano0x4e - DIRECTOR_APPOINTED: Steven Zelenkofske seat on Cadrenal Therapeutics, Inc., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-16T13:53:50.695151+00:00. event_id=alpha:event:transition:14q1tmgahests - COMMITTEE_CREATED: Audit · Chair; Compensation committee of Cadrenal Therapeutics, Inc., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-16T13:53:50.695151+00:00. event_id=alpha:event:transition:1edpq8w1j50vcq - COMMITTEE_MEMBER_ADDED: John R. Murphy member of Audit · Chair; Compensation, effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-16T13:53:50.695151+00:00. event_id=alpha:event:transition:1je4tn54rvp7v - COMMITTEE_CREATED: Audit; Compensation · Chair; Nominating and Governance committee of Cadrenal Therapeutics, Inc., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-16T13:53:50.695151+00:00. event_id=alpha:event:transition:12cgr0e4ifg8k - COMMITTEE_MEMBER_ADDED: Steven Zelenkofske member of Audit; Compensation · Chair; Nominating and Governance, effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-16T13:53:50.695151+00:00. event_id=alpha:event:transition:10nb90j1vulwxb - COMMITTEE_CREATED: Audit; Nominating and Governance · Chair committee of Cadrenal Therapeutics, Inc., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-16T13:53:50.695151+00:00. event_id=alpha:event:transition:1fmwkhnbcu3jt - COMMITTEE_MEMBER_ADDED: Glynn Wilson member of Audit; Nominating and Governance · Chair, effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-16T13:53:50.695151+00:00. event_id=alpha:event:transition:6o9p4715ny78j - DIRECTOR_APPOINTED: Quang X. Pham seat on Cadrenal Therapeutics, Inc., effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-16T13:53:50.695151+00:00. event_id=alpha:event:transition:rpupqoo9w6gq ## Scoped resources - `alpha://company/cadrenal-therapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/cadrenal-therapeutics-inc?format=record - `alpha://company/cadrenal-therapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/cadrenal-therapeutics-inc?format=record§ion=identity - `alpha://company/cadrenal-therapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/cadrenal-therapeutics-inc?format=record§ion=corporate-structure - `alpha://company/cadrenal-therapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/cadrenal-therapeutics-inc?format=record§ion=board - `alpha://company/cadrenal-therapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/cadrenal-therapeutics-inc?format=record§ion=committees - `alpha://company/cadrenal-therapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/cadrenal-therapeutics-inc?format=record§ion=leadership - `alpha://company/cadrenal-therapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/cadrenal-therapeutics-inc?format=record§ion=ownership - `alpha://company/cadrenal-therapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/cadrenal-therapeutics-inc?format=record§ion=financials - `alpha://company/cadrenal-therapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/cadrenal-therapeutics-inc?format=record§ion=capital-structure - `alpha://company/cadrenal-therapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/cadrenal-therapeutics-inc?format=record§ion=compensation - `alpha://company/cadrenal-therapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/cadrenal-therapeutics-inc?format=record§ion=governance - `alpha://company/cadrenal-therapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/cadrenal-therapeutics-inc?format=record§ion=shareholder-governance - `alpha://company/cadrenal-therapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/cadrenal-therapeutics-inc?format=record§ion=audit - `alpha://company/cadrenal-therapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/cadrenal-therapeutics-inc?format=record§ion=legal - `alpha://company/cadrenal-therapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/cadrenal-therapeutics-inc?format=record§ion=risk - `alpha://company/cadrenal-therapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/cadrenal-therapeutics-inc?format=record§ion=cyber - `alpha://company/cadrenal-therapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/cadrenal-therapeutics-inc?format=record§ion=ai-governance - `alpha://company/cadrenal-therapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/cadrenal-therapeutics-inc?format=record§ion=agents - `alpha://company/cadrenal-therapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/cadrenal-therapeutics-inc?format=record§ion=ecosystem - `alpha://company/cadrenal-therapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/cadrenal-therapeutics-inc?format=record§ion=events - `alpha://company/cadrenal-therapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/cadrenal-therapeutics-inc?format=record§ion=relationships - `alpha://company/cadrenal-therapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/cadrenal-therapeutics-inc?format=record§ion=assessments - `alpha://company/cadrenal-therapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/cadrenal-therapeutics-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:f227606f-090b-4b0c-a0c5-48947253569f:committee_appointment:14: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:john-r-murphy","name":"John R. Murphy"},"source_id":"board_seats"}` - Claim alpha:claim:company:f227606f-090b-4b0c-a0c5-48947253569f:committee_appointment:15: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:glynn-wilson","name":"Glynn Wilson"},"source_id":"board_seats"}` - Claim alpha:claim:company:f227606f-090b-4b0c-a0c5-48947253569f:committee_appointment:16: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:steven-zelenkofske","name":"Steven Zelenkofske"},"source_id":"board_seats"}` - Claim alpha:claim:company:f227606f-090b-4b0c-a0c5-48947253569f:committee_appointment:18: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:steven-zelenkofske","name":"Steven Zelenkofske"},"source_id":"board_seats"}` - Claim alpha:claim:company:f227606f-090b-4b0c-a0c5-48947253569f:committee_appointment:19: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:john-r-murphy","name":"John R. Murphy"},"source_id":"board_seats"}` - Claim alpha:claim:company:f227606f-090b-4b0c-a0c5-48947253569f:committee_appointment:21: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:glynn-wilson","name":"Glynn Wilson"},"source_id":"board_seats"}` - Claim alpha:claim:company:f227606f-090b-4b0c-a0c5-48947253569f:committee_appointment:22: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:steven-zelenkofske","name":"Steven Zelenkofske"},"source_id":"board_seats"}` ## Leadership - Glynn Wilson: Director, Audit; Nominating and Governance · Chair. Claim: alpha:claim:company:f227606f-090b-4b0c-a0c5-48947253569f:leadership_role:5. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:81eb49a3299237965867f83afc9ea915689b192f646ee7e9d8aaa7c51656e340. - John R. Murphy: Director, Audit · Chair; Compensation. Claim: alpha:claim:company:f227606f-090b-4b0c-a0c5-48947253569f:leadership_role:6. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:81eb49a3299237965867f83afc9ea915689b192f646ee7e9d8aaa7c51656e340. - Quang X. Pham: Director. Claim: alpha:claim:company:f227606f-090b-4b0c-a0c5-48947253569f:leadership_role:7. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:81eb49a3299237965867f83afc9ea915689b192f646ee7e9d8aaa7c51656e340. - Steven Zelenkofske: Director, Audit; Compensation · Chair; Nominating and Governance. Claim: alpha:claim:company:f227606f-090b-4b0c-a0c5-48947253569f:leadership_role:8. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:81eb49a3299237965867f83afc9ea915689b192f646ee7e9d8aaa7c51656e340. - James J. Ferguson III: Chief Medical Officer. Claim: alpha:claim:company:f227606f-090b-4b0c-a0c5-48947253569f:leadership_role:9. Valid from: 2026-03-31. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f9e247f1c2a947a649fb4a09c02f0eab54656ebc54f28a043b10479ac4161702. - Jeffrey Cole: Chief Operating Officer. Claim: alpha:claim:company:f227606f-090b-4b0c-a0c5-48947253569f:leadership_role:10. Valid from: 2026-03-31. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e035e50e7f880d34ea38dce95367e4f0afbed937cdc04f6a5726c1ac8745b6df. - Matthew Szot: Chief Financial Officer. Claim: alpha:claim:company:f227606f-090b-4b0c-a0c5-48947253569f:leadership_role:11. Valid from: 2026-03-31. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:bf29820a4b7b16db56b34dbbc589579fc55422287a8b2e8d1a8bcdf5ddbd1732. - Quang X. Pham: Chairman and Chief Executive Officer. Claim: alpha:claim:company:f227606f-090b-4b0c-a0c5-48947253569f:leadership_role:12. Valid from: 2026-03-31. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b1e8a1874073a7906a6a29597d58f5f07de5c316f424d36fdc437ff0ef04e6fc. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair John R. Murphy; Members John R. Murphy (Chair); Glynn Wilson; Steven Zelenkofske. Claim: alpha:claim:company:f227606f-090b-4b0c-a0c5-48947253569f:committee_record:13. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f69125e60a922af4049a6de7faa5ae4240ca71163d5d87572d68b56cd623012a. - Compensation: Chair Steven Zelenkofske; Members Steven Zelenkofske (Chair); John R. Murphy. Claim: alpha:claim:company:f227606f-090b-4b0c-a0c5-48947253569f:committee_record:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f69125e60a922af4049a6de7faa5ae4240ca71163d5d87572d68b56cd623012a. - Nominating and Governance: Chair Glynn Wilson; Members Glynn Wilson (Chair); Steven Zelenkofske. Claim: alpha:claim:company:f227606f-090b-4b0c-a0c5-48947253569f:committee_record:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f69125e60a922af4049a6de7faa5ae4240ca71163d5d87572d68b56cd623012a. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Cadrenal Therapeutics, Inc.. Claim: alpha:claim:company:f227606f-090b-4b0c-a0c5-48947253569f:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d9637186523f1fb1a239779d913d7385ad150b2da4f2c1ccf7ee9265493cc5d7. ## Entity Status - Public listing published. Claim: alpha:claim:company:f227606f-090b-4b0c-a0c5-48947253569f:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d9637186523f1fb1a239779d913d7385ad150b2da4f2c1ccf7ee9265493cc5d7. ## Published Fact - US. Claim: alpha:claim:company:f227606f-090b-4b0c-a0c5-48947253569f:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d9637186523f1fb1a239779d913d7385ad150b2da4f2c1ccf7ee9265493cc5d7. ## Committee Appointment - John R. Murphy: chair, Audit. Claim: alpha:claim:company:f227606f-090b-4b0c-a0c5-48947253569f:committee_appointment:14. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f69125e60a922af4049a6de7faa5ae4240ca71163d5d87572d68b56cd623012a. - Glynn Wilson: member, Audit. Claim: alpha:claim:company:f227606f-090b-4b0c-a0c5-48947253569f:committee_appointment:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f69125e60a922af4049a6de7faa5ae4240ca71163d5d87572d68b56cd623012a. - Steven Zelenkofske: member, Audit. Claim: alpha:claim:company:f227606f-090b-4b0c-a0c5-48947253569f:committee_appointment:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f69125e60a922af4049a6de7faa5ae4240ca71163d5d87572d68b56cd623012a. - Steven Zelenkofske: chair, Compensation. Claim: alpha:claim:company:f227606f-090b-4b0c-a0c5-48947253569f:committee_appointment:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f69125e60a922af4049a6de7faa5ae4240ca71163d5d87572d68b56cd623012a. - John R. Murphy: member, Compensation. Claim: alpha:claim:company:f227606f-090b-4b0c-a0c5-48947253569f:committee_appointment:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f69125e60a922af4049a6de7faa5ae4240ca71163d5d87572d68b56cd623012a. - Glynn Wilson: chair, Nominating and Governance. Claim: alpha:claim:company:f227606f-090b-4b0c-a0c5-48947253569f:committee_appointment:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f69125e60a922af4049a6de7faa5ae4240ca71163d5d87572d68b56cd623012a. - Steven Zelenkofske: member, Nominating and Governance. Claim: alpha:claim:company:f227606f-090b-4b0c-a0c5-48947253569f:committee_appointment:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f69125e60a922af4049a6de7faa5ae4240ca71163d5d87572d68b56cd623012a. ## Security Listing - CVKD (NASDAQ). Claim: alpha:claim:company:f227606f-090b-4b0c-a0c5-48947253569f:security_listing:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d9637186523f1fb1a239779d913d7385ad150b2da4f2c1ccf7ee9265493cc5d7. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:d9637186523f1fb1a239779d913d7385ad150b2da4f2c1ccf7ee9265493cc5d7: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/cadrenal-therapeutics-inc). - alpha:projection-evidence:document:81eb49a3299237965867f83afc9ea915689b192f646ee7e9d8aaa7c51656e340: [Cadrenal Therapeutics, Inc. DEF 14A 2025-07-31](https://www.sec.gov/Archives/edgar/data/1937993/000121390025069612/ea0250217-01.htm). - alpha:projection-evidence:document:f9e247f1c2a947a649fb4a09c02f0eab54656ebc54f28a043b10479ac4161702: [CVKD 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1937993/000121390026036946/ea0283741-10k_cadrenal.htm). - alpha:projection-evidence:document:e035e50e7f880d34ea38dce95367e4f0afbed937cdc04f6a5726c1ac8745b6df: [CVKD 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1937993/000121390026036946/ea0283741-10k_cadrenal.htm). - alpha:projection-evidence:document:bf29820a4b7b16db56b34dbbc589579fc55422287a8b2e8d1a8bcdf5ddbd1732: [CVKD 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1937993/000121390026036946/ea0283741-10k_cadrenal.htm). - alpha:projection-evidence:document:b1e8a1874073a7906a6a29597d58f5f07de5c316f424d36fdc437ff0ef04e6fc: [CVKD 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1937993/000121390026036946/ea0283741-10k_cadrenal.htm). - alpha:projection-evidence:f69125e60a922af4049a6de7faa5ae4240ca71163d5d87572d68b56cd623012a: [Audit](https://www.sec.gov/Archives/edgar/data/1937993/000121390025069612/ea0250217-01.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/cadrenal-therapeutics-inc) - [Public Markdown](https://registry.alpha.ac/companies/cadrenal-therapeutics-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/cadrenal-therapeutics-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/cadrenal-therapeutics-inc?format=jsonld) - MCP resource: `alpha://companies/cadrenal-therapeutics-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-17T02:38:38.082977+00:00; recorded 2026-10-17T02:38:38.082977+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.